IQVIA Holdings Inc. (IQV)
NYSE: IQV · Real-Time Price · USD
267.77
-3.85 (-1.42%)
At close: Sep 4, 2026, 4:00 PM EDT
272.50
+4.73 (1.77%)
After-hours: Sep 4, 2026, 7:30 PM EDT
IQVIA Holdings Employees
IQVIA Holdings had 93,000 employees as of December 31, 2025. The number of employees increased by 5,000 or 5.68% compared to the previous year.
Employees
93,000
Change (1Y)
5,000
Growth (1Y)
5.68%
Revenue / Employee
$182,613
Profits / Employee
$14,785
Market Cap
44.07B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 93,000 | 5,000 | 5.68% |
| Dec 31, 2024 | 88,000 | 1,000 | 1.15% |
| Dec 31, 2023 | 87,000 | 1,000 | 1.16% |
| Dec 31, 2022 | 86,000 | 7,000 | 8.86% |
| Dec 31, 2021 | 79,000 | 9,000 | 12.86% |
| Dec 31, 2020 | 70,000 | 3,000 | 4.48% |
| Dec 31, 2019 | 67,000 | 9,000 | 15.52% |
| Dec 31, 2018 | 58,000 | 3,000 | 5.45% |
| Dec 31, 2017 | 55,000 | 5,000 | 10.00% |
| Dec 31, 2016 | 50,000 | 13,900 | 38.50% |
| Dec 31, 2015 | 36,100 | 3,500 | 10.74% |
| Dec 31, 2014 | 32,600 | 4,400 | 15.60% |
| Dec 31, 2013 | 28,200 | 788 | 2.87% |
| Dec 31, 2012 | 27,412 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Labcorp Holdings | 71,000 |
| Quest Diagnostics | 57,000 |
| Agilent Technologies | 18,100 |
| Mettler-Toledo International | 18,100 |
| IDEXX Laboratories | 11,000 |
| Revvity | 11,000 |
| Illumina | 10,080 |
| Waters | 7,900 |
IQV News
- 3 days ago - Iqvia announces Predictive Clinical Development - TheFly
- 3 days ago - IQVIA's Predictive Clinical Development Provides Sponsors With Significant Efficiencies to Get Treatments to Market Faster - Business Wire
- 10 days ago - IQVIA Wins Multiple Industry Awards for AI and Technology Innovation Across Life Sciences and Healthcare - Business Wire
- 17 days ago - IQVIA's AI-Enabled Clinical Decision Support Tool Wins 2026 AI Breakthrough Award for Predictive Modeling Solution of the Year - Business Wire
- 20 days ago - IQVIA Ranked No. 1 Pharmaceutical Technology Provider by Everest Group - Business Wire
- 4 weeks ago - Iqvia, Medera partner to advance cardiac gene therapy - TheFly
- 4 weeks ago - IQVIA and Medera to Advance Cardiac Gene Therapy and Human-Based Drug Discovery - Business Wire
- 5 weeks ago - Iqvia price target raised to $247 from $221 at RBC Capital - TheFly